Dược phẩm

DHG

Dược Hậu Giang

100

+0.10%

Mkt Cap 1.3T

9.8

Strong Sell

Sentiment

+1.00

Impact

1.00

Momentum

+0.04

Fundamentals

+0.00

Volume

0.71

News Sentiment

Articles Analyzed

Dominant Sentiment

Positive

Positive 2

Negative 1

Neutral 1

Recent News

Apr 21, 2026

DHG Pharmaceutical faces potential loss of its public company status as retail shareholder ownership falls below the 10% minimum required by securities law, with major shareholders Taisho (51.01%) and SCIC (43.31%) holding most shares.

regulation change ↗ External source

7 Negative

Apr 20, 2026

VNDirect (VND) Q1 2026 Profit Up 43% as TP Securities (ORS) Surges 1,961%

VNDirect (VND) posted Q1 2026 pre-tax profit of VND 681 billion, a 43% year-on-year increase, as part of a broader earnings release wave. TP Securities (ORS) led with a 1,961% surge to VND 42 billion, while ACBS grew 67% to VND 303 billion, highlighting divergent performance in Vietnam's securities sector amid mixed market conditions.

earnings beat

10 Positive

Apr 10, 2026

On April 10th, the Vietnamese stock market maintained its positive momentum with VN-Index increasing over 17 points, led by strong performance in the energy, finance, and real estate sectors. Foreign investors were net buyers, focusing on TCB and HPG, while the information technology and some healthcare stocks saw declines.

↗ External source

4 Positive

Apr 10, 2026

The Ministry of Health has issued a directive to ensure a stable, timely, and reasonably priced supply of essential drugs, urging provinces, hospitals, and pharmaceutical companies to prevent shortages, hoarding, and unreasonable price increases while prioritizing domestic production.

↗ External source

7 Neutral

Related Stocks — Dược phẩm

DBD — Dược - Trang thiết bị y tế Bình Định DCL — Dược phẩm Cửu Long DMC — Xuất nhập khẩu Y tế Domesco IMP — Dược phẩm Imexpharm LDP — Dược Lâm Đồng - Ladophar MED — Dược Trung ương Mediplantex TRA — Traphaco

Stock Analysis